Neumora Therapeutics NMRA Stock
13.56 USD
{{ price }}
-3.211990%
{{change_pct}}%
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
2.15B USD
LOW - HIGH [24H]
13.44
-
13.97 USD
VOLUME [24H]
231.17K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-3.63 USD
Neumora Therapeutics Price Chart
Neumora Therapeutics NMRA Financial and Trading Overview
| Neumora Therapeutics stock price | 13.56 USD |
| Previous Close | 52.4 USD |
| Open | 52.4 USD |
| Bid | 0 USD x N/A |
| Ask | 0 USD x N/A |
| Day's Range | 52.41 - 52.41 USD |
| 52 Week Range | 52.41 - 52.41 USD |
| Volume | 0 USD |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.63 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NMRA Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Neumora Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 52.41 USD |
| 52 Week Low | 52.41 USD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
NMRA Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Neumora Therapeutics Stock
What is a current NMRA stock price?
Neumora Therapeutics NMRA stock price today per share is 13.56 USD.
How to purchase Neumora Therapeutics stock?
You can buy NMRA shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Neumora Therapeutics?
The stock symbol or ticker of Neumora Therapeutics is NMRA.
How many shares does Neumora Therapeutics have in circulation?
The max supply of Neumora Therapeutics shares is 158.89M.
What is Neumora Therapeutics Price to Earnings Ratio (PE Ratio)?
Neumora Therapeutics PE Ratio is now.
What was Neumora Therapeutics earnings per share over the trailing 12 months (TTM)?
Neumora Therapeutics EPS is -3.63 USD over the trailing 12 months.